(redirected from neuroleptic malignant syndrome)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to neuroleptic malignant syndrome: tardive dyskinesia, Serotonin syndrome
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for neuroleptic

References in periodicals archive ?
Neuroleptic malignant syndrome in a patient with tongue cancer: a report of a rare case.
Neuroleptic malignant syndrome can occur with atypical antipsychotic drugs such as olanzapine, particularly when risk factors are present.
Carroll BT and Suber SA (2009), the problem of atypical neuroleptic malignant syndrome.
Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report.
The presented case is of severe drug resistant neuroleptic malignant syndrome where patient remained in intensive care unit with ventilator support for a long time and finally responded to electroconvulsive therapy.
Keck PE Jr, Pope HG Jr, Cohen BM, McElroy SL, Nierenberg AA: Risk factors for neuroleptic malignant syndrome.
In recent years, CK elevations related to use of atypical antipsychotics have been reported in several case studies in the absence of neuroleptic malignant syndrome.
The next day, he had rhabdomyolysis, fever, and rigidity, and neuroleptic malignant syndrome was diagnosed.
Neuroleptic malignant syndrome (NMS) represents a cluster of adverse effects of antipsychotic medications including: hypertonicity, autonomic instability, fever, and cognitive disturbance.
Like similar drugs, it has many other serious potential risks, including strokes, heart problems, high blood sugar and diabetes, suicide, seizures, fainting, a drop in infection-fighting white blood cells, sedation and impaired thinking, and neuroleptic malignant syndrome, a life-threatening neurological disorder.
The notice emphasized that treatment should not be abruptly discontinued, because rapid withdrawal of dopamine agonists has been associated with a syndrome resembling neuroleptic malignant syndrome or akinetic crises.
The evaluation and management of patients with neuroleptic malignant syndrome.